[26] We showed that the predicted mRNA cleavage products were detectable both by size on agarose gel electrophoresis and by sequencing of the PCR product using two different siRNAs designed against either GAPD or BCL-XL genes in cultured ovarian cancer cells. The gene discussed is BCL2L1; the disease is ovarian carcinoma.